Led by the University of Exeter, the phase III clinical trial plans to launch across 8 NHS sites and will explore the use of low-dose ketamine combined with psychological support as a therapy for people with alcohol use disorder.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
